|
Market Closed -
NYSE
16:02:38 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 101.82 USD | +2.23% |
|
+1.72% | -18.73% |
| 10-08 | Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase | MT |
| 10-07 | Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder | CI |
| Market Cap | 172B 154B 144B 130B 246B 16,504B 248B 1,729B 677B 8,502B 647B 633B 27,335B | P/E 2026 * |
29.2x | P/E 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 196B 176B 164B 149B 280B 18,796B 282B 1,970B 771B 9,683B 737B 721B 31,132B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 3.54x |
| Free-Float |
86.16% | Yield 2026 * |
2.58% | Yield 2027 * | 2.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
Tradegate
| ABL | Real-time | |
London S.E.
| ABT | Delayed | |
Börse Stuttgart
| ABL | Delayed | |
Boerse Muenchen
| ABL | Real-time | |
Xetra
| ABL | Delayed | |
Deutsche Boerse AG
| ABL | Delayed | |
Borsa Italiana
| 1ABT | End-of-day quote | |
Mexican S.E.
| ABT * | End-of-day quote | |
CBOE
| Real-time | ||
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
Lima
| ABTUS | End-of-day quote | |
Wiener Boerse
| ABT | End-of-day quote | |
Swiss Exchange
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
Santiago S.E.
| ABTCL | End-of-day quote | |
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +2.23% | ||
| 1 week | +1.72% | ||
| Current month | +3.03% | ||
| 1 month | -0.13% | ||
| 3 months | +8.40% | ||
| 6 months | +1.52% | ||
| Current year | -18.73% |
| 1 week | 97.2 | 102.06 | |
| 1 month | 95.06 | 104.54 | |
| Current year | 81.97 | 129.46 | |
| 1 year | 81.97 | 133.34 | |
| 3 years | 81.97 | 141.23 | |
| 5 years | 81.97 | 142.6 | |
| 10 years | 37.38 | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Free | Director | 333 | 0.0000% | ||
| 9/30/26 | Free | Director | 318 | 0.0000% | ||
| 9/30/26 | Free | Director | 381 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.23% | +1.72% | -23.20% | +12.89% | 172B | ||
| +3.90% | +4.50% | -3.69% | +28.95% | 113B | ||
| +1.90% | -0.92% | -22.49% | +11.33% | 106B | ||
| +0.27% | +1.56% | -46.32% | -11.83% | 75.31B | ||
| +0.37% | +3.22% | +2.22% | +73.30% | 61.8B | ||
| +0.12% | +2.27% | +15.06% | +60.71% | 52.93B | ||
| +2.80% | +4.55% | +1.25% | -26.52% | 50.05B | ||
| +1.15% | -0.59% | -14.97% | +22.33% | 40.81B | ||
| -1.38% | -0.11% | - | - | 31.81B | ||
| +2.15% | -1.13% | +31.94% | +13.82% | 31.74B | ||
| Average | +0.89% | +2.04% | -6.69% | +20.55% | 73.64B | |
| Weighted average by Cap. | +1.04% | +2.17% | -12.63% | +19.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.99B 41.89B 38.01B 71.69B 4,807B 72.14B 504B 197B 2,476B 189B 184B 7,962B | 54.53B 48.87B 45.5B 41.29B 77.87B 5,222B 78.36B 547B 214B 2,690B 205B 200B 8,649B |
| Net income | 6.21B 5.57B 5.18B 4.7B 8.87B 595B 8.93B 62.33B 24.39B 306B 23.33B 22.82B 985B | 7.89B 7.07B 6.59B 5.98B 11.27B 756B 11.34B 79.21B 31B 389B 29.64B 28.99B 1,252B |
| Net Debt | 23.94B 21.45B 19.97B 18.12B 34.19B 2,292B 34.4B 240B 94B 1,181B 89.9B 87.92B 3,797B | 20.96B 18.78B 17.49B 15.87B 29.93B 2,007B 30.11B 210B 82.29B 1,034B 78.7B 76.97B 3,324B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | US$101.82 | +2.23% | 6,831,195 |
| 26-10-09 | US$99.60 | +1.13% | 6,962,016 |
| 26-10-08 | US$98.49 | -0.24% | 13,909,636 |
| 26-10-07 | US$98.73 | +0.58% | 9,392,437 |
| 26-10-06 | US$98.16 | -1.94% | 10,577,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions


















